Metsera responds to Pfizer litigation, will address claims in court
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Metsera Issues Statement in Response to Litigation
October 31, 2025 6:25 PM EDTNEW YORK, Oct. 31, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to litigation filed against the Company by Pfizer:
"Metsera disagrees with the allegations in Pfizer's complaint and will address them in the Delaware Court of Chancery."
Â
Disclosure Notice Â
This release contains forward-looking information about, among other topics, Pfizer's proposed... More
